GLP-1 Drugs Transform American Food Purchasing Habits

The increasing use of GLP-1 receptor agonist medications, such as Ozempic, is significantly altering food purchasing behaviors in the United States. Recent research conducted by Cornell University highlights that households utilizing these weight-loss drugs are reducing their grocery spending and shifting dietary preferences in ways that have implications for the food industry.

In a comprehensive study, researchers analyzed transaction records from Numerator, a market research firm that monitors grocery and restaurant purchases from approximately 150,000 households across the US. By correlating these records with surveys regarding the use of GLP-1 medications, the team was able to assess changes in food spending before and after the introduction of these drugs.

The findings reveal that within just six months of starting on a GLP-1 medication, households reduce their grocery spending by an average of 5.3%, with higher-income households seeing a reduction of 8%. The impact extends to fast-food establishments and coffee shops, which also experienced an approximate 8% decline in sales.

Sylvia Hristakeva from the Cornell SC Johnson College of Business noted, “The data show clear changes in food spending following adoption. After discontinuation, the effects become smaller and harder to distinguish from pre-adoption spending patterns.” This observation underscores the significant influence of appetite suppression associated with GLP-1 medications on consumer behavior.

The decreases in grocery spending were not uniform across all categories. Ultra-processed and calorie-dense foods, often linked to cravings, saw the most substantial declines, with sales of sweets and savory snacks dropping by around 10%. Interestingly, traditional staples such as eggs and meat also faced reduced sales. In contrast, certain categories like yogurt, fresh fruit, nutritional bars, and meat-based snacks witnessed increased popularity.

As the number of US households with at least one member on GLP-1 medication grows from 11% in late 2023 to over 16% by mid-2024, the food industry is adapting to these changing consumer preferences. Approximately one-third of those surveyed reported ceasing their use of GLP-1 drugs during the study period, resulting in a return to previous shopping habits characterized by higher consumption of less healthy foods.

With projections suggesting that by 2035, around 24 million Americans will be using GLP-1 drugs, food manufacturers are actively strategizing to retain their customer base. Justin Shimek, CEO of food innovation firm Mattson, emphasized the dual nature of this trend: “These medications are both a risk and opportunity for the food industry. Clearly, we believe this is going to be a time of disruption.”

The research indicates that GLP-1 users are consuming 66% less soda and alcohol, while 93% report eating smaller meals. Over 60% of participants stated they think about food less frequently. In a bid to target this demographic, Conagra Brands has started to label its Healthy Choice products as “GLP-1 Friendly,” despite maintaining their original formulations.

The Cornell researchers anticipate that food packaging, size, and marketing strategies will evolve in response to the growing market of GLP-1 users. Hristakeva stated, “At current adoption rates, even relatively modest changes at the household level can have meaningful aggregate effects. Understanding these demand shifts is therefore important for assessing food markets and consumer spending.”

While the study could not definitively attribute the decrease in food spending solely to GLP-1 medications, the correlation between appetite suppression and altered purchasing habits is evident. Analysts from Morgan Stanley remain optimistic regarding the restaurant sector, asserting that dining experiences extend beyond mere sustenance. Brian Harbour, who leads coverage of US restaurants and food distributors at Morgan Stanley, remarked that chains are likely to adapt over time to meet evolving consumer preferences, though they may face declining sales in the medium term.

The implications of these trends are significant, reshaping not just individual eating habits but also the broader landscape of the food industry. The study has been published in the Journal of Marketing Research, further contributing to the conversation about the intersection of health and consumer behavior.